www.fdanews.com/articles/198280-fda-clears-philips-remote-monitoring-defibrillator-platform
FDA Clears Philips’ Remote Monitoring Defibrillator Platform
July 30, 2020
Philips has earned 510(k) clearance from the FDA for its Tempus ALS platform, a remote patient monitoring and defibrillator system.
The system consists of a portable monitor that tracks vital signs and a defibrillator that connect wirelessly to share collected data and images to a web-based software platform.
The device and software platform “will help front line responders provide emergency care, diagnosis and treatment,” including defibrillation therapy and data management, the company said.